NGS-based Non-Invasive Prenatal Test

Simple, fast and safe NGS-NIPT

Our NGS NIPT service offers noninvasive prenatal test that screens for multiple fetal chromosomal aneuploidies using a single maternal blood draw. The basic test screens for T21 (Down syndrome), T18 (Edwards syndrome), and T13 (Patau syndrome).

Safe—Routine, noninvasive blood draw, just one tube (7–10 ml)Accurate—Directly analyzes cell-free fetal and maternal DNA with our proprietary algorithm

Easy—Test as early as 10 weeks gestational age (8 weeks of fetal age as determined by date of conception). No limitations in reference to ethnicity, BMI, ART or egg donor cases.

Fast—Results reported to partner laboratory in 3 - 5 business days after sample receipt. (Time to report may vary in times of exceptional demand.)